Patents by Inventor Kaniz KHALIFA

Kaniz KHALIFA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409565
    Abstract: Provided herein are pharmaceutical compositions comprising carotenoids, including liposomes that encapsulate carotenoids including ionizable carotenoids such as trans-crocetin. The provided compositions have uses in treating diseases, disorders and conditions associated with, but not limited to, infection, endotoxemia, inflammation, sepsis, ischemia, hypoxia, shock, stroke, lung injury, wound healing, traumatic injury, reperfusion injury, cardiovascular disease, kidney disease, liver disease, inflammatory disease, metabolic disease, pulmonary disorders, blood related disorders and hyperproliferative diseases such as cancer. Methods of making, delivering, and using the pharmaceutical compositions are also provided.
    Type: Application
    Filed: November 3, 2020
    Publication date: December 29, 2022
    Inventors: Clet NIYIKIZA, Victor Mandla MOYO, Bolin GENT, Zhenghong XU, Kaniz KHALIFA, Gwangseong KIM
  • Publication number: 20210283055
    Abstract: Provided herein are pharmaceutical compositions comprising carotenoids, including liposomes that encapsulate carotenoids including ionizable carotenoids such as trans-crocetin. The provided compositions have uses in treating diseases, disorders and conditions associated with, but not limited to, infection, endotoxemia, inflammation, sepsis, ischemia, hypoxia, shock, stroke, lung injury, wound healing, traumatic injury, reperfusion injury, cardiovascular disease, kidney disease, liver disease, inflammatory disease, metabolic disease, pulmonary disorders, blood related disorders and hyperproliferative diseases such as cancer. Methods of making, delivering, and using the pharmaceutical compositions are also provided.
    Type: Application
    Filed: May 3, 2019
    Publication date: September 16, 2021
    Inventors: Clet NIYIKIZA, Victor Mandla MOYO, Bolin GENG, Zhenghong XU, Kaniz KHALIFA, Gwangseong KIM
  • Publication number: 20210154140
    Abstract: This disclosure relates to a targeted PEGylated liposomal gemcitabine (PLG) composition comprising a PEGylated liposome encapsulating one or more agents comprising gemcitabine and a targeting moiety; pharmaceutical composition and methods comprising PLG or producing PLG; and manufacturing equipment for performing the methods.
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Inventors: Clet NIYIKIZA, Victor MOYO, Zhenghong XU, Kaniz KHALIFA
  • Patent number: 10940112
    Abstract: This disclosure relates to a targeted PEGylated liposomal gemcitabine (PLG) composition comprising a PEGylated liposome encapsulating one or more agents comprising gemcitabine and a targeting moiety; pharmaceutical composition and methods comprising PLG or producing PLG; and manufacturing equipment for performing the methods.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: March 9, 2021
    Assignee: L.E.A.F. Holdings Group LLC
    Inventors: Clet Niyikiza, Victor Moyo, Zhenghong Xu, Kaniz Khalifa
  • Publication number: 20170319482
    Abstract: This disclosure relates to a targeted PEGylated liposomal gemcitabine (PLG) composition comprising a PEGylated liposome encapsulating one or more agents comprising gemcitabine and a targeting moiety; pharmaceutical composition and methods comprising PLG or producing PLG; and manufacturing equipment for performing the methods.
    Type: Application
    Filed: May 4, 2017
    Publication date: November 9, 2017
    Inventors: Clet NIYIKIZA, Victor MOYO, Zhenghong XU, Kaniz KHALIFA